Tue: Nice plunges on mixed TASE
The Tel Aviv Stock Exchange saw mixed performance. The Tel Aviv 35 Index rose 0.29%, while the Tel Aviv 125 and BlueTech Global Indices fell. Teva Pharmaceuticals (TEVA) gained 3.75% after strong Q3 results, while Nice (NICE) dropped 7.07% due to layoff plans. Turnover was NIS 4.61B in equities and NIS 4.87B in bonds.
How this was made

The 30-second read
Why it matters
The only clearly actionable, company-specific catalyst with explicit detail is Nice’s 5% workforce layoff, which aligns with the largest single-name decline. Several other names are linked to Q3 results, but the article provides no figures, limiting conviction on the underlying drivers.
Market read
Traders can use the same-session catalysts to manage near-term positioning in the named movers, especially Nice’s restructuring headline.
What to watch
The article lacks the actual Q3 metrics and guidance for most companies, so traders should verify whether the declines were driven by revenue, margins, guidance, or one-off items before extending the move.
Background
This is a Tel Aviv market wrap describing index performance, FX levels, and top movers, with several US-listed Israeli companies tied to Q3 results and one restructuring announcement.
Ticker impact
Nice shares fell 7.07% after announcing it will lay off 5% of its workforce, making the restructuring a direct risk/sentiment catalyst.
Likely downside bias as the market prices restructuring risk and potential margin impacts.
The article ties the largest single-name drop directly to the workforce reduction, a same-session catalyst that typically drives immediate repricing.
Teva rose 3.75% on the Tel Aviv 35 Index after reporting strong third quarter results, indicating a positive earnings read-through.
Likely upward pressure as investors extrapolate improved fundamentals from the reported quarter.
The article explicitly links the biggest gain to strong third-quarter results, a direct fundamental catalyst.
Enlight Renewable Energy fell 2.13% after reporting its third quarter results, signaling the market reacted negatively to the quarter.
Likely continued weakness if investors focus on any underwhelming Q3 details.
The article states the move and that it followed Q3 results, but provides no specific Q3 figures to confirm the reason for the negative reaction.
Nova Ltd. fell 2.63% after reporting its third quarter results, indicating a negative earnings reaction.
Likely downside bias as the market digests the quarter’s implications.
The article links the decline to Q3 results but omits the specific figures or guidance details needed for higher confidence.
ICL fell 4.06% in the Tel Aviv market wrap, with the article presenting it as part of the day’s biggest decliners.
Near-term downside pressure possible, but catalyst uncertainty limits conviction.
ICL is named as a decliner, yet no specific news trigger is described in the text.
Market effects
Mixed earnings reactions across Israeli-listed tech/industrial names suggest selective risk appetite rather than a broad sector repricing.
Tel Aviv indices were mixed, implying idiosyncratic company catalysts dominated rather than a single macro driver.
Limited direct global spillover beyond sentiment for the specific US-listed Israeli tech/industrial names mentioned.
Counterpoint
The NICE layoff could be interpreted as proactive cost control that improves longer-term margins, so the initial selloff may be overdone without details on severance, savings, or demand outlook.
Key entities
- companyNice
Announced it will lay off 5% of its workforce; shares fell 7.07%.
- companyTeva Pharmaceutical Industries
Reported strong third quarter results; shares rose 3.75%.
- companyEnlight Renewable Energy
Reported third quarter results; shares fell 2.13%.
- companyNova Ltd.
Reported third quarter results; shares fell 2.63%.




